Malignant Neoplasm of Unknown Primary — Trials

Malignant Neoplasm of Unknown Primary — Trials · CancerIndex

Clinical trials

Registered studies

14,253 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4,158
Recruiting: 2,260
Ph III recruiting: 268
Growth YoY: +13.9%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,895)

clinicaltrialsPublishedShowing 51–100 of 911 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05396118	Simultaneous Hyperpolarized [1-13C]Pyruvate and 18F-FDG PET/MRS in Cancer Patients	unknown	Phase 2	15	Rigshospitalet, DenmarkOTHER	1	May 14, 2024	clinicaltrials
NCT04159974	RICE: Radio-Immuno-Chemotherapy of Cancer of the Esophagus(RICE)	unknown	Phase 2	56	University of CologneOTHER	1	May 9, 2024	clinicaltrials